{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:54:08Z","timestamp":1793084048070,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","award":["MAB 3\/2016"],"award-info":[{"award-number":["MAB 3\/2016"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Gorham-Stout disease is a rare condition characterized by vascular proliferation and the massive destruction of bone tissue. With less than 400 cases in the literature of Gorham-Stout syndrome, we performed a unique study combining whole-genome sequencing and RNA-Seq to probe the genomic features and differentially expressed pathways of a presented case, revealing new possible drivers and biomarkers of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present a case report of a white 45-year-old female patient with marked bone loss of the left humerus associated with vascular proliferation, diagnosed with Gorham-Stout disease. The analysis of whole-genome sequencing showed a dominance of large structural DNA rearrangements. Particularly, rearrangements in chromosomes seven, twelve, and twenty could contribute to the development of the disease, especially a gene fusion involving<jats:italic>ATG101<\/jats:italic>that could affect macroautophagy. The study of RNA-sequencing data from the patient uncovered the<jats:italic>PI3K<\/jats:italic>\/<jats:italic>AKT<\/jats:italic>\/<jats:italic>mTOR<\/jats:italic>pathway as the most affected signaling cascade in the Gorham-Stout lesional tissue. Furthermore, M2 macrophage infiltration was detected using immunohistochemical staining and confirmed by deconvolution of the RNA-seq expression data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The way that DNA and RNA aberrations lead to Gorham-Stout disease is poorly understood due to the limited number of studies focusing on this rare disease. Our study provides the first glimpse into this facet of the disease, exposing new possible therapeutic targets and facilitating the clinicopathological diagnosis of Gorham-Stout disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12920-022-01277-x","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T07:03:53Z","timestamp":1654499033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Marcos","family":"Y\u00e9benes Mayordomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofian","family":"Al Shboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"G\u00f3mez-Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Azfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Meynert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Salter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Oniscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Hupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5553-6991","authenticated-orcid":false,"given":"Javier Antonio","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"1277_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2106\/00004623-195537050-00008","volume":"37-A","author":"LW Gorham","year":"1955","unstructured":"Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am. 1955;37-A:985\u20131004.","journal-title":"J Bone Joint Surg Am"},{"key":"1277_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3121\/cmr.3.2.65","volume":"3","author":"DV Patel","year":"2005","unstructured":"Patel DV. Gorham\u2019s disease or massive osteolysis. Clin Med Res. 2005;3:65\u201374.","journal-title":"Clin Med Res"},{"key":"1277_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/os.12390","volume":"10","author":"M Li","year":"2018","unstructured":"Li M, et al. Successful management of Gorham-Stout disease in scapula and ribs: a case report and literature review. Orthop Surg. 2018;10:276\u201380.","journal-title":"Orthop Surg"},{"key":"1277_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbo.2015.05.001","volume":"4","author":"VV Yerganyan","year":"2015","unstructured":"Yerganyan VV, Body JJ, De Saint-Aubain N, Gebhart M. Gorham-Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid. J Bone Oncol. 2015;4:42\u20136.","journal-title":"J Bone Oncol"},{"key":"1277_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12891-020-03540-7","volume":"21","author":"Y Liang","year":"2020","unstructured":"Liang Y, et al. Gorham-Stout disease successfully treated with sirolimus (rapamycin): a case report and review of the literature. BMC Musculoskelet Disord. 2020;21:577.","journal-title":"BMC Musculoskelet Disord"},{"key":"1277_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s10038-020-0794-y","volume":"65","author":"A Nozawa","year":"2020","unstructured":"Nozawa A, et al. A somatic activating KRAS variant identified in an affected lesion of a patient with Gorham-Stout disease. J Hum Genet. 2020;65:995\u20131001.","journal-title":"J Hum Genet"},{"key":"1277_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","volume":"61","author":"Y Aoki","year":"2016","unstructured":"Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61:33\u20139.","journal-title":"J Hum Genet"},{"key":"1277_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01088","author":"C Mu\u00f1oz-Maldonado","year":"2019","unstructured":"Mu\u00f1oz-Maldonado C, Zimmer Y, Medov\u00e1 M. A comparative analysis of individual ras mutations in cancer biology. Front Oncol. 2019. https:\/\/doi.org\/10.3389\/fonc.2019.01088.","journal-title":"Front Oncol"},{"key":"1277_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1055\/s-0037-1604296","volume":"34","author":"H-L Nguyen","year":"2017","unstructured":"Nguyen H-L, Boon LM, Vikkula M. Vascular anomalies caused by abnormal signaling within endothelial cells: targets for novel therapies. Semin Interv Radiol. 2017;34:233\u20138.","journal-title":"Semin Interv Radiol"},{"key":"1277_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149831","author":"N Homayun-Sepehr","year":"2021","unstructured":"Homayun-Sepehr N, et al. KRAS-driven model of Gorham-Stout disease effectively treated with trametinib. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.149831.","journal-title":"JCI Insight"},{"key":"1277_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12891-019-3027-9","volume":"21","author":"C Zheng","year":"2019","unstructured":"Zheng C, et al. Gorham-Stout disease of the malleolus: a rare case report. BMC Musculoskelet Disord. 2019;21:3.","journal-title":"BMC Musculoskelet Disord"},{"key":"1277_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccell.2019.02.002","volume":"35","author":"CD Steele","year":"2019","unstructured":"Steele CD, et al. Undifferentiated sarcomas develop through distinct evolutionary pathways. Cancer Cell. 2019;35:441-456.e8.","journal-title":"Cancer Cell"},{"key":"1277_CR13","doi-asserted-by":"publisher","first-page":"15842","DOI":"10.18632\/oncotarget.4683","volume":"6","author":"S H\u00fcnten","year":"2015","unstructured":"H\u00fcnten S, Hermeking H. p53 directly activates cystatin D\/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3. Oncotarget. 2015;6:15842\u201356.","journal-title":"Oncotarget"},{"key":"1277_CR14","doi-asserted-by":"crossref","first-page":"5546711","DOI":"10.1155\/2021\/5546711","volume":"2021","author":"Z Yang","year":"2021","unstructured":"Yang Z, et al. UNC5B promotes vascular endothelial cell senescence via the ROS-mediated P53 pathway. Oxid Med Cell Longev. 2021;2021:5546711.","journal-title":"Oxid Med Cell Longev"},{"key":"1277_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4161\/auto.5.5.8249","volume":"5","author":"CA Mercer","year":"2009","unstructured":"Mercer CA, Kaliappan A, Dennis PB. A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy. Autophagy. 2009;5:649\u201362.","journal-title":"Autophagy"},{"key":"1277_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0959-437X(02)00309-X","volume":"12","author":"M Durbeej","year":"2002","unstructured":"Durbeej M, Campbell KP. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev. 2002;12:349\u201361.","journal-title":"Curr Opin Genet Dev"},{"key":"1277_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13395-017-0131-0","volume":"7","author":"ML Cox","year":"2017","unstructured":"Cox ML, et al. Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers. Skelet Muscle. 2017;7:15.","journal-title":"Skelet Muscle"},{"issue":"297","key":"1277_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/ar.22974","volume":"2007","author":"D Townsend","year":"2014","unstructured":"Townsend D. Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex. Anat Rec. 2014;2007(297):1694\u2013705.","journal-title":"Anat Rec"},{"key":"1277_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fgene.2018.00727","volume":"9","author":"M Younus","year":"2018","unstructured":"Younus M, et al. SGCD homozygous nonsense mutation (p.Arg97(\u2217)) causing limb-girdle muscular dystrophy type 2F (LGMD2F) in a consanguineous family: a case report. Front Genet. 2018;9:727.","journal-title":"Front Genet"},{"key":"1277_CR20","first-page":"85","volume":"19","author":"AF Mavrogenis","year":"2010","unstructured":"Mavrogenis AF, Zambirinis CP, Dimitriadis PA, Tsakanikas A, Papagelopoulos PJ. Gorham-stout disease. J Surg Orthop Adv. 2010;19:85\u201390.","journal-title":"J Surg Orthop Adv"},{"key":"1277_CR21","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1038\/onc.2008.247","volume":"27","author":"A Carracedo","year":"2008","unstructured":"Carracedo A, Pandolfi PP. The PTEN\u2013PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008;27:5527\u201341.","journal-title":"Oncogene"},{"key":"1277_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","volume":"4","author":"N Chalhoub","year":"2009","unstructured":"Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127\u201350.","journal-title":"Annu Rev Pathol"},{"key":"1277_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","volume":"4","author":"J Karar","year":"2011","unstructured":"Karar J, Maity A. PI3K\/AKT\/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51.","journal-title":"Front Mol Neurosci"},{"key":"1277_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","author":"AK Pandey","year":"2018","unstructured":"Pandey AK, et al. Mechanisms of VEGF (vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease. Hypertension. 2018. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10271.","journal-title":"Hypertension"},{"key":"1277_CR25","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:1\u20139.","journal-title":"Signal Transduct Target Ther"},{"key":"1277_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1084\/jem.20081056","volume":"205","author":"AM Timmer","year":"2008","unstructured":"Timmer AM, Nizet V. IKK\u03b2\/NF-\u03baB and the miscreant macrophage. J Exp Med. 2008;205:1255\u20139.","journal-title":"J Exp Med"},{"key":"1277_CR27","first-page":"1001","volume":"1","author":"UM Moll","year":"2003","unstructured":"Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res. 2003;1:1001\u20138.","journal-title":"Mol Cancer Res"},{"key":"1277_CR28","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4161\/auto.5.7.9296","volume":"5","author":"N Hosokawa","year":"2009","unstructured":"Hosokawa N, et al. Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy. 2009;5:973\u20139.","journal-title":"Autophagy"},{"key":"1277_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"},{"key":"1277_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fgene.2020.00605","volume":"11","author":"C Passarelli","year":"2020","unstructured":"Passarelli C, et al. Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy. Front Genet. 2020;11:605.","journal-title":"Front Genet"},{"key":"1277_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/71667","volume":"24","author":"AE Hughes","year":"2000","unstructured":"Hughes AE, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet. 2000;24:45\u20138.","journal-title":"Nat Genet"},{"issue":"1048\u20131054","key":"1277_CR32","first-page":"e1","volume":"166","author":"VL Luks","year":"2015","unstructured":"Luks VL, et al. Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166(1048\u20131054):e1-5.","journal-title":"J Pediatr"},{"key":"1277_CR33","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ajmg.a.35406","volume":"158A","author":"SMJ Hopman","year":"2012","unstructured":"Hopman SMJ, et al. PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A. 2012;158A:1719\u201323.","journal-title":"Am J Med Genet A"},{"key":"1277_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1089\/wound.2018.0850","volume":"8","author":"M Ozeki","year":"2019","unstructured":"Ozeki M, Fukao T. Generalized lymphatic anomaly and gorham-stout disease: overview and recent insights. Adv Wound Care. 2019;8:230\u201345.","journal-title":"Adv Wound Care"},{"key":"1277_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/B978-0-12-801238-3.62273-0","volume-title":"Encyclopedia of bone biology","author":"M Mathew","year":"2020","unstructured":"Mathew M, Goyal A, Khan A, Yuen T. Drugs for rare diseases of bone. In: Zaidi M, editor. Encyclopedia of bone biology. Cambridge: Academic Press; 2020. p. 711\u201322. https:\/\/doi.org\/10.1016\/B978-0-12-801238-3.62273-0."},{"key":"1277_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000436","volume":"37","author":"J R\u00f6ssler","year":"2015","unstructured":"R\u00f6ssler J, Saueressig U, Kayser G, von Winterfeld M, Klement GL. Personalized therapy for generalized lymphatic anomaly\/gorham-stout disease with a combination of Sunitinib and Taxol. J Pediatr Hematol Oncol. 2015;37: e481.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1277_CR37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1359\/JBMR.041113","volume":"20","author":"F Hammer","year":"2005","unstructured":"Hammer F, et al. Gorham-Stout disease-stabilization during bisphosphonate treatment. J Bone Miner Res Off J Am Soc Bone Miner Res. 2005;20:350\u20133.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"1277_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/pbc.25886","volume":"63","author":"A Nozawa","year":"2016","unstructured":"Nozawa A, et al. Gorham-stout disease of the skull base with hearing loss: dramatic recovery and antiangiogenic therapy. Pediatr Blood Cancer. 2016;63:931\u20134.","journal-title":"Pediatr Blood Cancer"},{"key":"1277_CR39","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","volume":"14","author":"S Shangary","year":"2008","unstructured":"Shangary S, Wang S. Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:5318\u201324.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1277_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrc991","volume":"3","author":"P Ch\u00e8ne","year":"2003","unstructured":"Ch\u00e8ne P. Inhibiting the p53\u2013MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer. 2003;3:102\u20139.","journal-title":"Nat Rev Cancer"},{"key":"1277_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/670842","volume":"2014","author":"T Faruqi","year":"2014","unstructured":"Faruqi T, et al. Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders. BioMed Res Int. 2014;2014: e670842.","journal-title":"BioMed Res Int"},{"key":"1277_CR42","first-page":"193","volume":"53","author":"HH Yeter","year":"2017","unstructured":"Yeter HH. Gorham-Stout disease or new entity on the basis of vasculopathy. Alex J Med. 2017;53:193\u20136.","journal-title":"Alex J Med"},{"key":"1277_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1359\/JBMR.051019","volume":"21","author":"S Colucci","year":"2006","unstructured":"Colucci S, et al. Gorham-stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res. 2006;21:207\u201318.","journal-title":"J Bone Miner Res"},{"key":"1277_CR44","doi-asserted-by":"publisher","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","DOI":"10.1038\/s41598-017-17204-5"},{"issue":"1","key":"1277_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/his.14108","volume":"77","author":"L Berben","year":"2020","unstructured":"Berben L, Wildiers H, Marcelis L, Antoranz A, Bosisio F, Hatse S, Floris G. Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software. Histopathology. 2020;77(1):79\u201391. https:\/\/doi.org\/10.1111\/his.14108.","journal-title":"Histopathology"},{"issue":"12","key":"1277_CR46","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101054","volume":"4","author":"S Al Shboul","year":"2021","unstructured":"Al Shboul S, Curran OE, Alfaro JA, Lickiss F, Nita E, Kowalski J, Naji F, Nenutil R, Ball KL, Krejcir R, Vojtesek B, Hupp TR, Brennan PM. Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival. Life Sci Alliance. 2021;4(12):e202101054. https:\/\/doi.org\/10.26508\/lsa.202101054.","journal-title":"Life Sci Alliance"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-022-01277-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T13:56:27Z","timestamp":1727358987000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-022-01277-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1186\/s12920-022-01277-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"25 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of general approval for use of surgically obtained tissue and approved by NHS Lothian NRS BioResource and the Public Health Office. The Lothian NRS BioResource is a HRA approved research tissue bank (REC Ref: 20\/ES\/0061, previously 15\/ES\/0094). This approval was given by East of Scotland Research Ethics Service REC 1. As part of this approval, the REC Committee confirmed that the favorable ethical opinion also applies to all research projects conducted in the UK using tissue or data supplied by the tissue bank, subject to the submission of an approved application to the tissue bank.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and genomic data was obtained from the patient. A copy of the consent form is available upon request from the corresponding authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interest in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}